TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation

Molecular Immunology

Volumn 36, Issue 10, 1999, Pages 647-658

  Van Eyndhoven, W G ^a   Gamper, C J ^a,b   Cho, E ^a   Mackus, W J M ^a   Lederman, S ^a  

^a Columbia University ^*  (United States)

^b Integrated Program in Cellular   (United States)

Author keywords

Molecular biology; Signal transduction; T cell B cell collaboration

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ZINC FINGER PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; DELETION MUTANT; ENZYME ACTIVITY; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; RNA SPLICING; T LYMPHOCYTE ACTIVATION; VIRUS LATENCY;

ALTERNATIVE SPLICING; CELL LINE, TRANSFORMED; CELLS, CULTURED; GENE DELETION; GENE EXPRESSION; HUMANS; LYMPHOCYTES; NF-KAPPA B; PROTEIN ISOFORMS; PROTEINS; RNA, MESSENGER; TNF RECEPTOR-ASSOCIATED FACTOR 3; VARIATION (GENETICS);

EID: 0032823472     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00079-6     Document Type: Article

References (43)

1. Alt F.W., Bothwell A.L., Knapp M., Siden E., Mather E., Koshland M., Baltimore D. Synthesis of secreted and membrane-bound immunoglobulin μ heavy chains is directed by mRNAs that differ at their 3′ ends. Cell. 20:1980;293-301.
2. Arch R.H., Thompson C.B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)- nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell Biol. 18:1998;558-565.
3. Attar R.M., Macdonald-Bravo H., Raventos-Suarez C., Durham S.K., Bravo R. Expression of constitutively active IκB β in T cells of transgenic mice: persistent NF-κB activity is required for T-cell immune responses. Mol. Cell Biol. 18:1998;477-487.
4. Berberich I., Shu G.L., Clark E.A. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:1994;4357-4366.
5. Boucher L.M., Marengere L.E., Lu Y., Thukral S., Mak T.W. Binding sites of cytoplasmic effectors TRAF1, 2, 3 on CD30 and other members of the TNF receptor superfamily. Biochem. Biophys. Res. Commun. 233:1997;592-600.
6. Brink R., Lodish H.F. Tumor necrosis factor receptor (TNRF)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-κB activation. J. Biol. Chem. 273:1998;4129-4134.
7. Castigli E., Alt F.W., Davidson L., Bottaro A., Mizoguchi E., Bhan A.K., Geha R.S. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA. 91:1994;12135-12139.
8. Cheng G., Baltimore D. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-κB activation. Genes Dev. 10:1996;963-973.
9. Cheng G., Cleary A.M., Ye Z-s, Hong D.I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 267:1995;1494-1497.
10. Dadgostar H., Cheng G. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-κB activation but is dispensable for c-Jun N-terminal kinase signaling. J. Biol. Chem. 273:1998;24775-24780.
11. Force W.R., Cheung T.C., Ware C.F. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor. J. Biol. Chem. 272:1997;30835-30840.
12. Gedrich R.W., Gilfillan M.C., Duckett C.S., Van Dongen J.L., Thompson C.B. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271:1996;12852-12858.
13. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W., Gerondakis S. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:1998;663-674.
14. Horwitz B.H., Zelazowski P., Shen Y., Wolcott K.M., Scott M.L., Baltimore D., Snapper C.M. The p65 subunit of NF-κB is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3. J. Immunol. 162:1999;1941-1946.
15. Hostager B.S., Hsing Y., Harms D.E., Bishop G.A. Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 157:1996;1047-1053.
16. Hsing Y., Bishop G.A. Requirement for nuclear factor-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J. Immunol. 162:1999;2804-2811.
17. Hu H.M., O'Rourke K., Boguski M.S., Dixit V.M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:1994;30069-30072.
18. Ishida T., Mizushima Si, Azuma S., Kobayashi N., Tojo T., Suzuki K., Aizawa S., Watanabe T., Mosialos G., Kieff E., Yamamoto T., Inoue J. Identification of TRAF6, a novel tumor necrosis factor receptor- associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:1996;28745-28748.
19. Ishida T.K., Tojo T., Aoki T., Kobayashi N., Ohishi T., Watanabe T., Yamamoto T., Inoue J. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA. 93:1996;9437-9442.
20. Kashiwada M., Shirakata Y., Inoue J.I., Nakano H., Okazaki K., Okumura K., Yamamoto T., Nagaoka H., Takemori T. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. J. Exp. Med. 187:1998;237-244.
21. Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., Yosida N., Kishimoto T., Kikutani H. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:1994;167-178.
22. Kawamata S., Hori T., Imura A., Takaori-Kondo A., Uchiyama T. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation. J. Biol. Chem. 273:1998;5808-5814.
23. Krajewski S., Zapata J.M., Krajewska M., Vanarsdale T., Shabaik A., Gascoyne R.D., Reed J.C. Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family. J. Immunol. 159:1997;5841-5852.
24. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3 K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
25. Mosialos G., Birkenbach M., Yalamanchili R., Vanarsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
26. Pullen S.S., Miller H.G., Everdeen D.S., Dang T.T.A., Crute J.J., Kehry M.R. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry. 37:1998;11836-11845.
27. Regnier C.H., Tomasetto C., Moog-Lutz C., Chenard M.P., Wendling C., Basset P., Rio M.C. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270:1995;25715-25721.
28. Renshaw B.R., Fanslow W.C3., Armitage R.J., Campbell K.A., Liggitt D., Wright B., Davison B.L., Maliszewski C.R. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1994;1889-1900.
29. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-κ-B by TNF Receptor 2 and CD40. Science. 269:1995;1424-1427.
30. Rothe M., Wong S.C., Henzel W.J., Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
31. Rothe M., Xiong J., Shu H.B., Williamson K., Goddard A., Goeddel D.V. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc. Natl. Acad. Sci. USA. 93:1996;8241-8246.
32. Sato T., Irie S., Reed J.C. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Letters. 358:1995;113-118.
33. Screaton G.R., Xu X.N., Olsen A.L., Cowper A.E., Tan R., McMichael A.J., Bell J.I. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad Sci. USA. 94:1997;4615-4619.
34. Snapper C.M., Zelazowski P., Rosas F.R., Kehry M.R., Tian M., Baltimore D., Sha W.C. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, Ig class switching. J. Immunol. 156:1996;183-191.
35. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA. 94:1997;9792-9796.
36. Takeuchi M., Rothe M., Goeddel D.V. Anatomy of TRAF2. Distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271:1996;19935-19942.
37. Tran K., Merika M., Thanos D. Distinct functional properties of IκB α and IκB β Mol. Cell Biol. 17:1997;5386-5399.
38. van Eyndhoven W.G., Frank D., Kalachikov S., Cleary A.M., Hong D.I., Cho E., Nasr S., Perez A.J., Mackus W.J.M., Cayanis E., Wellington S., Fischer S.G., Warburton D., Lederman S. A single gene for human TRAF-3 at chromosome 14q32.3 encodes a variety of mRNA species by alternative polyadenylation, mRNA splicing and transcription initiation. Molecular Immunology. 35:1998;1189-2106.
39. Vanarsdale T.L., Vanarsdale S.L., Force W.R., Walter B.N., Mosialos G., Kieff E., Reed J.C., Ware C.F. Lymphotoxin-β receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl. Acad. Sci. USA. 94:1997;2460-2465.
40. Xu J., Foy T.M., Laman J.D., Elliott E.A., Dunn J.J., Waldschmidt T.J., Elsemore J., Noelle R.J., Flavell R.A. Mice deficient for the CD40 ligand. Immunity. 1:1994;423-431.
41. Xu Y., Cheng G., Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity. 5:1996;407-415.
42. Yamamoto H., Kishimoto T., Minamoto S. NF-κB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27. J. Immunol. 161:1998;4753-4759.
43. Yang Y., Chang J.F., Parnes J.R., Fathman C.G. T cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA. J. Exp. Med. 188:1998;247-254.